Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 165 mg - capsule, hard - excipient ingredients: titanium dioxide; microcrystalline cellulose; gelatin; hypromellose; poloxamer; sucrose; sodium lauryl sulfate; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 125 mg - capsule, hard - excipient ingredients: microcrystalline cellulose; sucrose; hypromellose; poloxamer; gelatin; sodium lauryl sulfate; titanium dioxide; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 40 mg - capsule, hard - excipient ingredients: iron oxide yellow; hypromellose; poloxamer; sucrose; gelatin; sodium lauryl sulfate; titanium dioxide; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ain medicare sdn. bhd. - modified fluid gelatin -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

aurobindo pharma limited, india - atomoxetine - hard gelatin capsules - 40

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: pharmakon biotec inc.; distributor: mirabell medical corp. - multivitamins , minerals - hard gelatin capsule - formulation each hard gelatin capsule contains: ferrous fumarate-105mg zinc sulphate monohydrate-28mg magnesium sulfate-1.8mg ascorbic acid (vitamin c)-75mg folic acid (vitamin b9)-0.4mcg cyanocobalamin (vitamin b12)-2.8mcg

Kenya - English - Pharmacy and Poisons Board

surgilinks limited p.o.box: 14461-00800 nairobi, kenya - tacrolimus capsules usp 5 mg - hard gelatin capsules - each hard gelatin contains: tacrolimus usp 5mg - tacrolimus

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - calcium chloride dihydrate; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate; sodium chloride; succinylated gelatin - solution for infusion - succinylated gelatin 40 mg/ml l; magnesium chloride hexahydrate 0.20 mg/ml l; calcium chloride dihydrate 0.15 mg/ml l; potassium chloride 0.30 mg/ml l; sodium acetate trihydrate 3.27 mg/ml l; sodium chloride 5.55 mg/ml l - gelatin agents - gelaspan 4% b.braun is a colloidal plasma volume substitute in an isotonic, fully balanced electrolyte solution for:• prophylaxis and emergency treatment of imminent or manifest relative or absolute hypovolaemia and shock;

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - sodium acetate trihydrate 1,635 g/500 ml; potassium chloride 0,3 mg/ml; magnesium chloride hexahydrate 0,2 mg/ml; sodium chloride 5,55 mg/ml; calcium chloride dihydrate 0,075 g/500 ml; gelatin, modified 40 mg/ml - solution for infusion - sodium chloride 5.55 mg/ml; gelatin, modified 40 mg/ml; potassium chloride 0.3 mg/ml; magnesium chloride hexahydrate 0.2 mg/ml; calcium chloride dihydrate; sodium acetate trihydrate - gelatin agents

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

b. braun melsungen ag - sodium acetate trihydrate 1,635 g/500 ml; potassium chloride 0,3 mg/ml; magnesium chloride hexahydrate 0,2 mg/ml; sodium chloride 5,55 mg/ml; calcium chloride dihydrate 0,075 g/500 ml; gelatin, modified 40 mg/ml - solution for infusion - calcium chloride dihydrate; potassium chloride 0.3 mg/ml; sodium chloride 5.55 mg/ml; sodium acetate trihydrate; magnesium chloride hexahydrate 0.2 mg/ml; gelatin, modified 40 mg/ml - gelatin agents